Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I DeGraw

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Drug and Chemical Toxicology|January 1, 1985
Metabolic and toxicologic study of an artificial sweetener, oxime VC Mitoma, E M Acton, J I DeGraw, et al.
Cancer Treatment Reports|July 1, 1987
Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor modelsF A Schmid, F M Sirotnak, G M Otter, et al.
Biochemical Pharmacology|December 15, 1988
Analogs of tetrahydrofolate directed at folate-dependent purine biosynthetic enzymes. Characteristics of mediated entry and transport-related resistance in L1210 cells for 5,10-dideazatetrahydrofolate and two 10-alkyl derivativesF M Sirotnak, G M Otter, J R Piper, et al.
Journal of Medicinal Chemistry|January 1, 1974
Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductaseJ I DeGraw, V H Brown, W T Colwell, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor propertiesF M Sirotnak, F A Schmid, L L Samuels, et al.
Cancer Chemotherapy and Pharmacology|September 23, 1998
A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in miceF M Sirotnak, J I DeGraw, W T Colwell, et al.
Cancer Treatment Reports|July 1, 1978
Antitumor properties of a new folate analog, 10-deaza-aminopterin, in miceF M Sirotnak, J I DeGraw, D M Moccio, et al.
Journal of Medicinal Chemistry|July 23, 1993
Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterinJ I DeGraw, W T Colwell, J R Piper, et al.
Cancer Treatment Reports|May 1, 1985
New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude miceF A Schmid, F M Sirotnak, G M Otter, et al.
Journal of Medicinal Chemistry|January 24, 1992
Synthesis and antifolate properties of 5,10-ethano-5,10-dideazaaminopterinJ I DeGraw, P H Christie, W T Colwell, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Drug and Chemical Toxicology|January 1, 1985
Metabolic and toxicologic study of an artificial sweetener, oxime VC Mitoma, E M Acton, J I DeGraw, et al.
Cancer Treatment Reports|July 1, 1987
Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor modelsF A Schmid, F M Sirotnak, G M Otter, et al.
Biochemical Pharmacology|December 15, 1988
Analogs of tetrahydrofolate directed at folate-dependent purine biosynthetic enzymes. Characteristics of mediated entry and transport-related resistance in L1210 cells for 5,10-dideazatetrahydrofolate and two 10-alkyl derivativesF M Sirotnak, G M Otter, J R Piper, et al.
Journal of Medicinal Chemistry|January 1, 1974
Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductaseJ I DeGraw, V H Brown, W T Colwell, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
10-Ethyl-10-deaza-aminopterin: structural design and biochemical, pharmacologic, and antitumor propertiesF M Sirotnak, F A Schmid, L L Samuels, et al.
Cancer Chemotherapy and Pharmacology|September 23, 1998
A new analogue of 10-deazaaminopterin with markedly enhanced curative effects against human tumor xenografts in miceF M Sirotnak, J I DeGraw, W T Colwell, et al.
Cancer Treatment Reports|July 1, 1978
Antitumor properties of a new folate analog, 10-deaza-aminopterin, in miceF M Sirotnak, J I DeGraw, D M Moccio, et al.
Journal of Medicinal Chemistry|July 23, 1993
Synthesis and antitumor activity of 10-propargyl-10-deazaaminopterinJ I DeGraw, W T Colwell, J R Piper, et al.
Cancer Treatment Reports|May 1, 1985
New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude miceF A Schmid, F M Sirotnak, G M Otter, et al.
Journal of Medicinal Chemistry|January 24, 1992
Synthesis and antifolate properties of 5,10-ethano-5,10-dideazaaminopterinJ I DeGraw, P H Christie, W T Colwell, et al.
Pageof 5